Livongo Health, Inc.
LVGO
Market Cap$14.2B
Close$
Share Statistics
| Market cap | $14.20 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.0 (-%) |
| Earnings per Share | $-0.39 |
| Beta | - |
| Outstanding Shares | 101,585,000 |
| Avg 30 Day Volume | 1,877,923 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
ESG Score
No data
About Livongo Health, Inc.
615 employees
CEO: Zane M. Burke Livongo Health, Inc. engages in the development and operation of consumer digital health platform. It offers Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health...